Biohaven (BHVN) Stock Forecast & Price Target

$9.71 -0.43 (-4.27%)

Closing price 03:59 PM Eastern

Extended Trading

$9.67 -0.04 (-0.38%)

As of 07:40 PM Eastern

Compare

Biohaven - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 18 Analyst Ratings

Sell
1

Hold
5

Buy
12

Based on 18 Wall Street analysts who have issued ratings for Biohaven in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 1 has given a sell rating, 5 have given a hold rating, 9 have given a buy rating, and 3 have given a strong buy rating for BHVN.

Consensus Price Target

$22.47
131.45% Upside

According to the 18 analysts' twelve-month price targets for Biohaven, the average price target is $22.47. The highest price target for BHVN is $75.00, while the lowest price target for BHVN is $9.00. The average price target represents a forecasted upside of 131.45% from the current price of $9.71.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for BHVN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Biohaven and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BHVN Analyst Ratings Over Time

Type	Current Forecast 5/5/25 to 5/5/26	1 Month Ago 4/5/25 to 4/5/26	3 Months Ago 2/4/25 to 2/4/26	1 Year Ago 5/5/24 to 5/5/25
Strong Buy	3 Strong Buy rating(s)	3 Strong Buy rating(s)	2 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	9 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)	14 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$22.47	$22.64	$25.57	$62.54
Forecasted Upside	131.45% Upside	131.21% Upside	132.89% Upside	176.84% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

BHVN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BHVN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Biohaven Stock vs. The Competition

Type	Biohaven	Medical Companies	S&P 500
Consensus Rating Score	2.78	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	131.45% Upside	938.20% Upside	14.74% Upside
News Sentiment Rating	Positive News See Recent BHVN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/5/2026	Royal Bank Of Canada 3 of 5 stars	Leonid Timashev 5 of 5 stars	Lower Target	Outperform	$23.00 ➝ $22.00	+134.92%
4/13/2026	Canaccord Genuity Group 4 of 5 stars		Initiated Coverage	Buy	$21.00	+128.83%
4/2/2026	Citigroup 4 of 5 stars	Samantha Semenkow Not Rated	Boost Target	Buy	$14.00 ➝ $17.00	+72.75%
3/11/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Van Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$15.00 ➝ $30.00	+182.43%
3/9/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Raymond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Strong-Buy
3/4/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$11.00 ➝ $10.00	-6.19%
3/3/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marc Goodman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$15.00	+40.71%
2/6/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
1/6/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terence Flynn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$26.00 ➝ $21.00	+121.87%
12/29/2025	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell (D-)
Get the Latest News and Ratings for BHVN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biohaven and its competitors with MarketBeat's FREE daily newsletter.
12/26/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Myles Minter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Perform
11/26/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$26.00 ➝ $11.00	+17.12%
11/20/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tessa Romero Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$47.00 ➝ $15.00	+57.15%
11/18/2025	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$16.00	+93.59%
11/6/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Pickering Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform	$34.00 ➝ $9.00	+8.26%
11/5/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Skorney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$42.00	+200.75%
11/5/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$10.00	+23.41%
5/13/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pete Stavropoulos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
3/20/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Buy	$60.00	+108.84%
9/23/2024	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$66.00 ➝ $76.00	+67.55%
9/16/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy	$57.00	+49.68%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:39 PM ET.

BHVN Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Biohaven is $22.47, with a high forecast of $75.00 and a low forecast of $9.00.
: 18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Biohaven in the last year. There is currently 1 sell rating, 5 hold ratings, 9 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" BHVN shares.
: According to analysts, Biohaven's stock has a predicted upside of 131.45% based on their 12-month stock forecasts.
: Over the previous 90 days, Biohaven's stock had 1 upgrade by analysts.
: Biohaven has been rated by research analysts at Canaccord Genuity Group, Citigroup, HC Wainwright, Leerink Partners, Raymond James Financial, Royal Bank Of Canada, TD Cowen, and The Goldman Sachs Group in the past 90 days.
: Analysts like Biohaven more than other "medical" companies. The consensus rating for Biohaven is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how BHVN compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Biohaven Recommendations

This page (NYSE:BHVN) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biohaven (BHVN) Stock Forecast & Price Target

Biohaven - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BHVN Analyst Ratings Over Time

BHVN Analyst Recommendations By Month

BHVN Price Targets by Month

Biohaven Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

BHVN Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Biohaven Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biohaven (BHVN) Stock Forecast & Price Target

Biohaven - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

BHVN Analyst Ratings Over Time

BHVN Analyst Recommendations By Month

BHVN Price Targets by Month

Biohaven Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

BHVN Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Biohaven Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools